Advertisement
Life Sciences
Subscribe to Life Sciences
View Sample

FREE Email Newsletter

Biological sample prep time cut dramatically

October 16, 2014 8:40 am | by Stephen P Wampler, Lawrence Livermore National Laboratory | News | Comments

When Lawrence Livermore National Laboratory researchers invented the field of biological accelerator mass spectrometry (AMS) in the late 1980s, the process of preparing the samples was time-consuming and cumbersome. Physicists and biomedical researchers used torches, vacuum lines, special chemistries and high degrees of skill to convert biological samples into graphite targets that could then be run through the AMS system.

Study reveals optimal particle size for anticancer nanomedicines

October 16, 2014 8:10 am | News | Comments

Nanomedicines consisting of nanoparticles for targeted drug delivery to specific tissues and cells offer new solutions for cancer diagnosis and therapy. Understanding the interdependency of physiochemical properties of nanomedicines, in correlation to their biological responses and functions, is crucial for their further development of as cancer-fighters.

Ultrasound reveals secrets of deadly abdominal aortic aneurysms

October 16, 2014 7:56 am | by Emil Venere, Purdue Univ. | News | Comments

Researchers are exploring the usefulness of ultrasound imaging to study dangerous abdominal aortic aneurysms, a bulging of the aorta that is usually fatal when it ruptures and for which there is no effective medical treatment. Abdominal aortic aneurysms are the 13th leading cause of death in the U.S., killing about 15,000 annually.

Advertisement

Big step in battling bladder disease

October 16, 2014 7:46 am | by Rob Matheson, MIT News Office | News | Comments

The millions of people worldwide who suffer from the painful bladder disease known as interstitial cystitis (IC) may soon have a better, long-term treatment option, thanks to a controlled-release, implantable device invented by Massachusetts Institute of Technology Prof. Michael Cima and other researchers. The device is a pretzel-shaped silicone tube that could be inserted into the bladder, slowly releasing lidocaine over two weeks.

Scientists create new protein-based material with some nerve

October 15, 2014 9:24 am | by Sarah Yang, UC Berkeley | News | Comments

Univ. of California, Berkeley scientists have taken proteins from nerve cells and used them to create a “smart” material that is extremely sensitive to its environment. This marriage of materials science and biology could give birth to a flexible, sensitive coating that is easy and cheap to manufacture in large quantities.

Effects of high-risk Parkinson’s mutation are reversible

October 15, 2014 9:01 am | by Amy Pullan, Media Relations Office, University of Sheffield | News | Comments

Researchers from the Univ. of Sheffield have found vital new evidence on how to target and reverse the effects caused by one of the most common genetic causes of Parkinson’s. Mutations in a gene called LRRK2 carry a well-established risk for Parkinson’s disease, however the basis for this link is unclear.  

Scientists map key moment in assembly of DNA-splitting molecular machine

October 15, 2014 8:22 am | News | Comments

The proteins that drive DNA replication are some of the most complex machines on Earth and the process involves hundreds of atomic-scale moving parts that rapidly interact and transform. Now, scientists have pinpointed crucial steps in the beginning of the replication process, including surprising structural details about the enzyme that "unzips" and splits the DNA double helix so the two halves can serve as templates for DNA duplication.

Is copper prostate cancer’s Kryptonite?

October 15, 2014 7:41 am | by Duke Medicine News and Communications | News | Comments

Like discriminating thieves, prostate cancer tumors scavenge and hoard copper that is an essential element in the body. But such avarice may be a fatal weakness. Researchers at Duke Medicine have found a way to kill prostate cancer cells by delivering a trove of copper along with a drug that selectively destroys the diseased cells brimming with the mineral, leaving non-cancer cells healthy.

Advertisement

Rock-dwelling microbes remove methane from deep sea

October 14, 2014 1:26 pm | by Ker Than, Caltech | News | Comments

Methane-breathing microbes that inhabit rocky mounds on the seafloor could be preventing large volumes of the potent greenhouse gas from entering the oceans and reaching the atmosphere, according to a new study. The rock-dwelling microbes represent a previously unrecognized biological sink for methane and as a result could reshape scientists' understanding of where this greenhouse gas is being consumed in subseafloor habitats.

Discovery of cellular snooze button advances cancer and biofuel research

October 14, 2014 12:53 pm | by Michigan State Univ. Media Communications | News | Comments

The discovery of a cellular snooze button has allowed a team of Michigan State Univ. scientists to potentially improve biofuel production and offer insight on the early stages of cancer. The discovery finds the protein CHT7 is a likely repressor of cellular quiescence, or resting state. This cellular switch, which influences algae’s growth and oil production, also wields control of cellular growth—and tumor growth—in humans.

ALS progression linked to increased protein instability

October 14, 2014 8:14 am | by Jon Weiner, Lawrence Berkeley National Laboratory | News | Comments

A new study by scientists from The Scripps Research Institute, Lawrence Berkeley National Laboratory and other institutions suggests a cause of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. The team's work supports a common theme whereby loss of protein stability leads to disease.

Obama reviews foreign, domestic response to Ebola

October 13, 2014 6:38 pm | by Jim Kuhnhenn - Associated Press - Associated Press | News | Comments

President Barack Obama urged his top national security and public health officials on Monday to incorporate lessons from the most recent Texas Ebola infection into the U.S.'s response plans to the deadly virus. He also called on the international community to deliver assistance more quickly to the countries of West Africa that are struggling against the disease.

All that glitters is...slimy? Gold nanoparticles measure snot stickiness

October 13, 2014 10:40 am | News | Comments

Some people might consider mucus an icky bodily secretion best left wrapped in a tissue, but to a group of researchers in North Carolina, snot is an endlessly fascinating subject. The team has developed a way to use gold nanoparticles and light to measure the stickiness of the slimy substance that lines our airways. The new method could help doctors better monitor and treat lung diseases such as cystic fibrosis.

Advertisement

Scientists create mimic of “good” cholesterol to fight heart disease, stroke

October 13, 2014 10:28 am | News | Comments

Researchers at The Scripps Research Institute have created a synthetic molecule that mimics “good” cholesterol and have shown it can reduce plaque buildup in the arteries of animal models. The molecule, taken orally, improved cholesterol in just two weeks.

DNA’s security system unveiled

October 13, 2014 9:04 am | by Bill Hathaway, Yale Univ. | Videos | Comments

As befitting life’s blueprint, DNA is surrounded by an elaborate security system that assures crucial information is imparted without error. The security is provided by a double membrane perforated by protein channels that block unwanted material from entering the nucleus and promote entry of key messengers.

What to do about the dwindling stock of antibiotics

October 13, 2014 8:57 am | by Diana Lutz, Washington Univ. in St. Louis | News | Comments

The Centers for Disease Control and Prevention has said that at least 2 million Americans are sickened by antibiotic resistant infections each year and survive. Twenty-three thousand die. These experiences leave deep impressions not just on the patients but on their family and friends.

Bio-inspired “nano-cocoons” offer targeted drug delivery against cancer

October 13, 2014 8:39 am | by Matt Shipman, North Carolina State Univ. | News | Comments

Biomedical engineering researchers have developed a drug delivery system consisting of nanoscale “cocoons” made of DNA that target cancer cells and trick the cells into absorbing the cocoon before unleashing anticancer drugs. The new system is DNA-based, which means it is biocompatible and less toxic to patients than systems that use synthetic materials.

Can all U.S. hospitals safely treat Ebola?

October 13, 2014 4:38 am | by Marilynn Marchione - AP Chief Medical Writer - Associated Press | News | Comments

A breach of infection control resulting in a Dallas health worker getting Ebola raises fresh questions about whether hospitals truly can safely take care of people with the deadly virus, as health officials insist is possible. Even in the U.S., with the best conditions and protective gear available, mistakes can happen that expose more people to Ebola, the new case reveals.

Autism as a disorder of prediction

October 10, 2014 11:13 am | by Anne Trafton, MIT News Office | News | Comments

Autism is characterized by many different symptoms: difficulty interacting with others, repetitive behaviors and hypersensitivity to sound and other stimuli. Massachusetts Institute of Technology neuroscientists have put forth a new hypothesis that accounts for these behaviors and may provide a neurological foundation for many of the disparate features of the disorder.

Molecular structure of Hep C envelope protein unveiled

October 10, 2014 9:09 am | by Laura Mgrdichian, Brookhaven National Laboratory | News | Comments

Hepatitis C, an infectious disease of the liver caused by the hepatitis C virus (HCV), affects 160 million people worldwide. There’s no vaccine for HCV and the few treatments that are available do not work on all variants of the virus. Before scientists can develop potential vaccines and additional therapies they must first thoroughly understand the molecular-level activity that takes place when the virus infects a host cell.

Charged graphene gives DNA a stage to perform molecular gymnastics

October 10, 2014 8:12 am | by Liz Ahlberg, Physical Sciences Editor, Univ. of Illinois, Urbana-Champaign | News | Comments

When Illinois researchers set out to investigate a method to control how DNA moves through a tiny sequencing device, they didn’t know they were about to witness a display of molecular gymnastics. Fast, accurate and affordable DNA sequencing is the first step toward personalized medicine.

DNA nanofoundries cast custom-shaped metal nanoparticles

October 10, 2014 7:50 am | by Kat J. McAlpine, Wyss Institute for Biologically Inspired Engineering | News | Comments

Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard Univ. have unveiled a new method to form tiny 3-D metal nanoparticles in prescribed shapes and dimensions using DNA, nature's building block, as a construction mold. The ability to mold inorganic nanoparticles out of materials such as gold and silver in precisely designed 3-D shapes is a significant breakthrough.

Of bio-hairpins and polymer-spaghetti

October 9, 2014 11:02 am | News | Comments

When a sturdy material becomes soft and spongy, one usually suspects damage. But this is not always the case, especially in biological cells. By looking at microscopic biopolymer networks, researchers in Germany revealed that such materials soften by undergoing a transition from an entangled spaghetti of filaments to aligned layers of bow-shaped filaments that slide past each other. This finding may explain how other filaments flow.

Researchers capture images of elusive protein HIV uses to infect cells

October 9, 2014 11:00 am | by Bill Hathaway, Yale Univ. | News | Comments

HIV is adept at eluding immune system responses because the protein it uses to infect cells is constantly changing. Now a team of researchers including scientists from Yale Univ. have stripped the cloak from this master of disguise, providing a high-resolution image of this surface spike protein and monitoring how it constantly changes its shape, information that suggests new ways to attack the virus through drugs and vaccines.

“Cyberwar” against cancer gets boost from intelligent nanocarriers

October 9, 2014 10:48 am | News | Comments

New research involving scientists in the U.S. and Israel offers new insight into the lethal interaction between cancer cells and the immune system's communications network. The study authors devised a new computer program that models a specific channel of cell-to-cell communication involving exosomes that both cancer and immune cells harness to communicate with other cells. This “cyberwarfare” model reveals three distinct states of cancer.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading